BCM
BML Capital Management Portfolio holdings
AUM
$131M
This Quarter Return
+1.74%
1 Year Return
+89.45%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$127M
AUM Growth
+$127M
(+17%)
Cap. Flow
-$27.7M
Cap. Flow
% of AUM
-21.86%
Top 10 Holdings %
Top 10 Hldgs %
79.82%
Holding
38
New
9
Increased
10
Reduced
3
Closed
3
Top Buys
| 1 |
THRX
Theseus Pharmaceuticals, Inc. Common Stock
THRX
|
$4.49M |
| 2 |
Design Therapeutics
DSGN
|
$2.73M |
| 3 |
CNTB
Connect Biopharma
CNTB
|
$2.43M |
| 4 |
OKUR
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
|
$2.1M |
| 5 |
Atea Pharmaceuticals
AVIR
|
$2.02M |
Top Sells
| 1 |
Tourmaline Bio
TRML
|
$45.9M |
| 2 |
Neurogene
NGNE
|
$1.43M |
| 3 |
Passage Bio
PASG
|
$1.35M |
| 4 |
Athira Pharma
ATHA
|
$608K |
| 5 |
Retractable Technologies
RVP
|
$595K |
Sector Composition
| 1 | Healthcare | 62.72% |
| 2 | Technology | 1.48% |
| 3 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Aclaris Therapeutics
ACRS
$209M
| $686K | 0.52% | +653,107 | New | +$686K |
|
|
27
Neurogene
NGNE
$264M
| $478K | 0.36% | 24,666 -73,998 | -75% | -$1.43M |
|
28
Q32 Bio
QTTB
$20.9M
| $455K | 0.34% | +748,108 | New | +$455K |
|
29
CalciMedica
CALC
$37.7M
| $416K | 0.32% | 145,424 +56,643 | +64% | +$162K |
|
30
NextCure
NXTC
$13.5M
| $349K | 0.26% | 306,465 | – | – |
|
|
TLIS
31
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $318K | 0.24% | +42,743 | New | +$318K |
|
32
Abercrombie & Fitch
ANF
$4.46B
| – | – | 0 | – | – |
|
33
Build-A-Bear
BBW
$803M
| – | – | 0 | – | – |
|
|
34
Passage Bio
PASG
$22.7M
| – | – | -2,058,767 | Closed | -$1.35M |
|
35
Invesco QQQ Trust
QQQ
$364B
| – | – | 0 | – | – |
|
|
36
Retractable Technologies
RVP
$25.1M
| – | – | -499,959 | Closed | -$595K |
|
37
Surrozen
SRZN
$104M
| – | – | -89,271 | Closed | -$43.7K |
|
38
Wingstop
WING
$9.16B
| – | – | 0 | – | – |
|